Stacy R. Lindborg's most recent trade in Imunon Inc was a trade of 2,977 shares done at an average price of $1.1 . Disclosure was reported to the exchange on Oct. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.08 per share. | 09 Oct 2026 | 2,977 | 116,174 (0%) | 0% | 1.1 | 3,215 | - |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.41 per share. | 25 Sep 2026 | 6,697 | 113,197 (0%) | 0% | 1.4 | 9,443 | - |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.47 per share. | 11 Sep 2026 | 5,504 | 105,580 (0%) | 0% | 1.5 | 8,091 | Common Stock |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.60 per share. | 28 Aug 2026 | 6,822 | 100,076 (0%) | 0% | 1.6 | 10,915 | Common Stock |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.65 per share. | 14 Aug 2026 | 6,615 | 93,254 (0%) | 0% | 1.7 | 10,915 | Common Stock |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.59 per share. | 31 Jul 2026 | 5,010 | 86,639 (0%) | 0% | 1.6 | 7,966 | Common Stock |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.83 per share. | 17 Jul 2026 | 4,907 | 81,629 (0%) | 0% | 1.8 | 8,980 | Common Stock |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.91 per share. | 02 Jul 2026 | 2,534 | 76,722 (0%) | 0% | 1.9 | 4,840 | Common Stock |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.72 per share. | 25 Jun 2026 | 67,150 | 74,188 (0%) | 0% | 1.7 | 115,498 | Common Stock |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.82 per share. | 18 Jun 2026 | 1,803 | 7,038 (0%) | 0% | 1.8 | 3,281 | Common Stock |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.06 per share. | 05 Jun 2026 | 1,593 | 5,235 (0%) | 0% | 2.1 | 3,282 | Common Stock |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.20 per share. | 22 May 2026 | 1,491 | 3,642 (0%) | 0% | 2.2 | 3,280 | Common Stock |
| Brainstorm Cell Therapeutics | Stacy R. Lindborg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | 02 Jan 2026 | 56,187 | 56,187 | - | - | Stock Option (Right to Buy) | ||
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | 06 Sep 2025 | 1,667 | 0 | - | - | Restricted Stock | ||
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Sep 2025 | 1,667 | 3,584 (0%) | 0% | 0 | Common Stock | |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | 04 Aug 2025 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | ||
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | 14 Mar 2025 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | ||
| Brainstorm Cell Therapeutics | Stacy R. Lindborg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 20,000 | 48,229 (0%) | 0% | 0 | Common Stock | |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | 10 Sep 2024 | 63,602 | 302,768 | - | - | Stock Option (Right to Buy) | ||
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | 06 Sep 2024 | 25,000 | 25,000 | - | - | Restricted Stock Units | ||
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 16 Aug 2024 | 25,000 | 264,166 (0%) | 0% | 1.0 | 24,500 | Imunon Common Stock |
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | 12 Jun 2024 | 112,500 | 239,166 | - | - | Stock Option (Right to Buy) | ||
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director, President and CEO | 13 May 2024 | 112,500 | 126,666 | - | - | Stock Option (Right to Buy) | ||
| Imunon Inc | Dr. Stacy R. Lindborg, PhD | Director | 15 Mar 2024 | 4,500 | 14,166 | - | - | Stock Option (Right to Buy) | ||
| Brainstorm Cell Therapeutics | Stacy R. Lindborg | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 241,935 | 423,435 (1%) | 0% | 0 | Common Stock | |
| Brainstorm Cell Therapeutics | Stacy R. Lindborg | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2023 | 35,000 | 170,000 (0%) | 0% | 0 | Common Stock | |
| Brainstorm Cell Therapeutics | Stacy R. Lindborg | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2023 | 75,000 | 135,000 (0%) | 0% | 0 | Common Stock | |
| Imunon Inc | Dr. Stacy R. Lindborg | Director | 17 Mar 2023 | 2,000 | 9,666 | - | - | Stock Option (Right to Buy) | ||
| Brainstorm Cell Therapeutics | Stacy R. Lindborg | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2022 | 35,000 | 60,000 (0%) | 0% | 0 | Common Stock | |
| Imunon Inc | Dr. Stacy R. Lindborg | Director | 13 Jun 2022 | 2,500 | 7,666 | - | - | Option to Purchase Celsion Common Stock | ||
| Imunon Inc | Dr. Stacy R. Lindborg | Director | 04 Mar 2022 | 2,500 | 5,166 | - | - | Option to Purchase Celsion Corporation Common Stock |